Integrated Wealth Concepts’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.48M | Sell |
35,492
-480
| -1% | -$63.2K | 0.03% | 526 |
|
|
2026
Q1 | $5.01M | Buy |
35,972
+20,046
| +126% | +$2.81M | 0.04% | 427 |
|
|
2025
Q4 | $1.95M | Sell |
15,926
-14,155
| -47% | -$1.72M | 0.02% | 537 |
|
|
2025
Q3 | $3.34M | Sell |
30,081
-1,440
| -5% | -$164K | 0.03% | 499 |
|
|
2025
Q2 | $3.49M | Buy |
31,521
+4,452
| +16% | +$474K | 0.04% | 441 |
|
|
2025
Q1 | $3.03M | Buy |
27,069
+382
| +1% | +$39.4K | 0.04% | 465 |
|
|
2024
Q4 | $2.47M | Buy |
26,687
+1,194
| +5% | +$108K | 0.03% | 494 |
|
|
2024
Q3 | $2.14M | Sell |
25,493
-251
| -1% | -$19.2K | 0.03% | 525 |
|
|
2024
Q2 | $1.77M | Buy |
25,744
+926
| +4% | +$61.8K | 0.02% | 550 |
|
|
2024
Q1 | $1.82M | Buy |
24,818
+219
| +0.9% | +$16.8K | 0.03% | 555 |
|
|
2023
Q4 | $1.99M | Sell |
24,599
-3,616
| -13% | -$281K | 0.03% | 483 |
|
|
2023
Q3 | $2.11M | Buy |
28,215
+338
| +1% | +$26K | 0.04% | 434 |
|
|
2023
Q2 | $2.15M | Sell |
27,877
-4,220
| -13% | -$337K | 0.04% | 434 |
|
|
2023
Q1 | $2.66M | Buy |
32,097
+14,376
| +81% | +$1.19M | 0.05% | 322 |
|
|
2022
Q4 | $1.52M | Sell |
17,721
-1,451
| -8% | -$115K | 0.04% | 381 |
|
|
2022
Q3 | $1.18M | Sell |
19,172
-382
| -2% | -$24.1K | 0.04% | 389 |
|
|
2022
Q2 | $1.21M | Sell |
19,554
-3,944
| -17% | -$244K | 0.04% | 395 |
|
|
2022
Q1 | $1.4M | Buy |
23,498
+3,051
| +15% | +$195K | 0.04% | 322 |
|
|
2021
Q4 | $1.48M | Buy |
20,447
+1,555
| +8% | +$107K | 0.04% | 315 |
|
|
2021
Q3 | $1.32M | Buy |
18,892
+6,690
| +55% | +$470K | 0.04% | 328 |
|
|
2021
Q2 | $840K | Buy |
12,202
+276
| +2% | +$18.4K | 0.03% | 399 |
|
|
2021
Q1 | $771K | Sell |
11,926
-439
| -4% | -$28.3K | 0.03% | 355 |
|
|
2020
Q4 | $720K | Buy |
12,365
+25
| +0.2% | +$1.51K | 0.03% | 319 |
|
|
2020
Q3 | $780K | Buy |
12,340
+5,117
| +71% | +$355K | 0.05% | 257 |
|
|
2020
Q2 | $556K | Buy |
7,223
+3,016
| +72% | +$231K | 0.04% | 264 |
|
|
2020
Q1 | $315K | Sell |
4,207
-1,248
| -23% | -$86.2K | 0.03% | 302 |
|
|
2019
Q4 | $354K | Buy |
5,455
+939
| +21% | +$61.1K | 0.03% | 332 |
|
|
2019
Q3 | $286K | Sell |
4,516
-506
| -10% | -$33.1K | 0.03% | 322 |
|
|
2019
Q2 | $322K | Buy |
+5,022
| New | +$330K | 0.04% | 256 |
|
|
2018
Q4 | – | Sell |
-2,580
| Closed | -$201K | – | 277 |
|
|
2018
Q3 | $201K | Buy |
+2,580
| New | +$195K | 0.06% | 243 |
|
Other funds holding GILD
Integrated Wealth Concepts's GILD Position: Q2 2026 in Review
Integrated Wealth Concepts reduced its Gilead Sciences (GILD) stake by 1.3% in Q2 2026, selling an estimated $63.2K and leaving 35,492 shares worth $4.48M. The position accounts for 0.03% of the portfolio, ranked #526.
Integrated Wealth Concepts first reported a position in GILD in Q3 2018 and has held it in 30 quarters since. The position peaked at $5.01M in Q1 2026. 2,299 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Integrated Wealth Concepts held 35,492 shares of Gilead Sciences worth $4.48M as of Q2 2026.
- Integrated Wealth Concepts sold 480 Gilead Sciences shares in Q2 2026, an estimated $63.2K.
- Gilead Sciences made up 0.03% of Integrated Wealth Concepts's portfolio in Q2 2026, its #526 holding.
- Integrated Wealth Concepts first reported a position in Gilead Sciences in Q3 2018 and has held it in 30 quarters since.
- Integrated Wealth Concepts's Gilead Sciences position peaked at $5.01M in Q1 2026.
- 2,299 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.